Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Rationale Novel synthetic opioids (NSOs) are emerging in recreational drug markets worldwide. In particular, 2-benzylbenzimidazole 'nitazene' compounds are problematic NSOs associated with serious clinical consequences, including fatal respiratory depression. Evidence from in vitro studies shows that alkoxy chain length can influence the potency of nitazenes at the mu-opioid receptor (MOR). However, structure-activity relationships (SARs) of nitazenes for inducing opioid-like effects in animal models are not well understood compared to relevant opioids contributing to the ongoing opioid crisis (e.g., fentanyl).Objectives Here, we examined the in vitro and in vivo effects of nitazene analogues with varying alkoxy chain lengths (i.e., metonitazene, etonitazene, isotonitazene, protonitazene, and butonitazene) as compared to reference opioids (i.e., morphine and fentanyl).Methods and results Nitazene analogues displayed nanomolar affinities for MOR in rat brain membranes and picomolar potencies to activate MOR in transfected cells. All compounds induced opioid-like effects on locomotor activity, hot plate latency, and body temperature in male mice, and alkoxy chain length markedly influenced potency. Etonitazene, with an ethoxy chain, was the most potent analogue in MOR functional assays (EC 50 = 30 pM, E max = 103%) and across all in vivo endpoints (ED 50 = 3-12 μg/kg). In vivo SARs revealed that ethoxy, isopropoxy, and propoxy chains engendered higher potencies than fentanyl, whereas methoxy and butoxy analogues were less potent. MOR functional potencies, but not MOR affinities, were positively correlated with in vivo potencies to induce opioid effects.Conclusions Overall, our data show that certain nitazene NSOs are more potent than fentanyl as MOR agonists in mice, highlighting concerns regarding the high potential for overdose in humans who are exposed to these compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the presence of a nitazene analogue even at trace amounts, which could be below the cut-off for detection with NTS, may readily give rise to dangerous opioid effects in (unknowing) users.”
From Nitazene test strips: a laboratory evaluation (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The potency of nitazenes is a major concern, as many analogues are substantially more potent than morphine and, in some cases, more potent than fentanyl.”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Kliewer, A., Schmiedel, F., Sianati, S., Bailey, A., Bateman, J. T., Levitt, E. S., Williams, J. T., Christie, M. J., & Schulz, S. (2019) · Nature Communications · doi:10.1038/s41467-018-08162-1 · Cited by 291
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
Self-citationMolecular recognition of morphine and fentanyl by the human μ-opioid receptor
Zhuang, Y., Wang, Y., He, B., He, X., Zhou, X. E., Guo, S., Rao, Q., Yang, J., Liu, J., Zhou, Q., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.041 · Cited by 273
Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling
Kliewer, A., Gillis, A., Hill, R., Schmiedel, F., Bailey, C., Kelly, E., Henderson, G., Christie, M. J., & Schulz, S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15004 · Cited by 245
O’Donnell, J., Tanz, L. J., Gladden, R. M., Davis, N. L., & Bitting, J. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7050e3 · Cited by 235
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Self-citationCritical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Gillis, A., Kliewer, A., Kelly, E., Henderson, G., Christie, M. J., Schulz, S., & Canals, M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.009 · Cited by 159
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146
Research works printed but not linked: 6
- Brandenberger H (1974) Die Rolle des Massenspektrometers im toxikologisch-chemischen Laboratorium. Deutsche Lebensmittel-Rundschau 70: 31 – 39
- EMCDDA (2022c) New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System. 10.2810/396103 · doi:10.2810/396103
- Krotulski A, Walton SE, Mohr ALA, Logan BK (2022a) 2022 Q1 NPS Opioid Trend Report. https://www.cfsre.org/images/trendreports/2022-Q1-NPS-Opioids-Trend-Report.pdf
- Morris H (2009) Synthetic opioids: the most addictive drugs in the world. In: Hamilton’s Pharmacopoeia. Vice News: Hamilton’s Pharmacopeia. https://www.vice.com/en/article/9bdymy/hamiltons-pharmacopeia-804-v16n4
- Sorokin VI (1999a) Etonitazene encountered in Moscow. Microgram 32: 239 – 244
- Sorokin VI (1999b) llegal synthesis of etonitazene. Journal of the Clandestine Laboratory Investigating Chemists Association 9: 20
Cited by
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“Shorter (i.e., methyl) or longer (i.e., propyl and butyl) tails lead to less potent analogues (Vandeputte et al. 2021; Kanamori et al. 2023; Glatfelter et al. 2023; Kozell et al. 2024).”
BackgroundMethodResultInfluentialSelf-citationKozell, L. B., Eshleman, A. J., Wolfrum, K. M., Swanson, T. L., Bloom, S. H., Benware, S., Schmachtenberg, J. L., Schutzer, K. A., Schutzer, W. E., Janowsky, A., et al. (2024) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002052 · Cited by 42
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Self-citationNitazene test strips: a laboratory evaluation
De Vrieze, L. M., Stove, C. P., & Vandeputte, M. M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01078-8 · Cited by 34
“…( 12 ), N -pyrrolidino isotonitazene citrate ( 13 ), N -piperidinyl 4’-hydroxy nitazene citrate ( 14 ), N -piperidinyl metonitazene citrate ( 15 ), N -piperidinyl etonitazene citrate ( 16 ), N -piperidinyl protonitazene citrate ( 17 ), N -piperidinyl isotonitazene citrate ( 18 ),…”
BackgroundSelf-citationVandeputte, M. M., Glatfelter, G. C., Walther, D., Layle, N. K., St. Germaine, D. M., Ujváry, I., Iula, D. M., Baumann, M. H., & Stove, C. P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107503 · Cited by 35
Self-citation
Metadata
- Authors
- Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H.
- Affiliations
- National Institutes of Health (US)
- Ghent University (BE)
- National Institute on Drug Abuse (US)
- Corresponding author
- Glatfelter, Grant C.
- ORCID
- Venue
- Psychopharmacology
- Published
- 2023-09-02
- Volume
- 240
- Issue
- 12
- Pages
- 2573-2584
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC12892259
- OpenAlex
- W4386391091
- Cited by
- 52
- References
- 50
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 14 · 2023: 1
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- National Institute on Drug Abuse (DA 000523-13, DA000606)
- Ghent University Special Research Fund (01J15517)
- Research Foundation-Flanders (V434122N)
- FWO (1S81522N, G069419N)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- nitazenes, novel synthetic opioids, alkoxy chain length, mu-opioid receptor, structure-activity relationship, opioid potency, etonitazene, isotonitazene, opioid overdose, respiratory depression, opioid epidemic
- MeSH terms
- Alcohols, Amines, Analgesics, Opioid, Animals, Benzimidazoles, Fentanyl, Humans, Male, Receptors, Opioid, mu, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose. https://app.cochat.ai/papers/10.1007/s00213-023-06451-2
- The paper
- Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023). Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose. Psychopharmacology. https://doi.org/10.1007/s00213-023-06451-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.